Current Edition

Acceleron

Merck started its Acceleron pursuit at $160 per share, but CEO Davis balked at paying more than $180

Merck’s new CEO Robert Davis has big shoes to fill after taking the reins from Kenneth Frazier at the start of July. Just two weeks …

Continue Reading →